Title : ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer.

Pub. Date : 2015 May 15

PMID : 25971350






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: One-third of estrogen (ER+) and/or progesterone receptor-positive (PGR+) breast tumors treated with Tamoxifen (TAM) do not respond to initial treatment, and the remaining 70% are at risk to relapse in the future. Tamoxifen progesterone receptor Homo sapiens
2 BACKGROUND: One-third of estrogen (ER+) and/or progesterone receptor-positive (PGR+) breast tumors treated with Tamoxifen (TAM) do not respond to initial treatment, and the remaining 70% are at risk to relapse in the future. Tamoxifen progesterone receptor Homo sapiens